Dale Broadrick sold $525 of BRTX
owner at BioRestorative Therapies, Inc.. 278 shares at an average of $1.89, traded Nov 27, 2023, filed Dec 1, 2023.
Score components
- +12Role10% owner
- 0Trade size$525 at market
- 0Share of holdings soldSold 0.1% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -6.0%, 3m -18.9%, 6m -32.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001021771-23-000116, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 27, 2023 | SOpen-market sale Common Stock | -278 | $1.89 | $525 | 327,295 | Dec 1, 2023 |
Related signals
Other insiders at BioRestorative Therapies, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $1,757 1,112 shares | -0% | |
| 36Weak | BRTXbuy BioRestorative Therapies, Inc. | Francisco Silva VP of Research and Development | $10k 8,308 shares | +6% | |
| 52Moderate | BRTXbuy BioRestorative Therapies, Inc. | Dale Broadrick owner | $206k 160,000 shares | +50% | |
| 42Moderate | BRTXbuy BioRestorative Therapies, Inc. | Dale Broadrick owner | $162k 120,000 shares | +37% | |
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $469 250 shares | -0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $903 300 shares | +0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $5,375 1,800 shares | +1% | |
| 36Weak | BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $2,877 1,000 shares | +1% | |
| 41Moderate | BioRestorative Therapies, Inc. | Francisco Silva VP of Research and Development | $2,467 943 shares | +1% | |
| 18Weak | BRTXbuy BioRestorative Therapies, Inc. | Francisco Silva VP of Research and Development | $2,973 806 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.